Curis
CRIS
#10258
Rank
โ‚น2.01 B
Marketcap
โ‚น50.29
Share price
-1.52%
Change (1 day)
-72.03%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): -โ‚น315.89

According to Curis's latest financial reports the company's current EPS (TTM) is -โ‚น342.39. In 2024 the company made an earnings per share (EPS) of -โ‚น655.86 an increase over its 2023 EPS that were of -โ‚น842.44.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น315.89-51.84%
2024-โ‚น655.86-22.15%
2023-โ‚น842.44-26.17%
2022-โ‚น1,14122.3%
2021-โ‚น932.94-25.37%
2020-โ‚น1,250-30.93%
2019-โ‚น1,810-2.02%
2018-โ‚น1,847
2016-โ‚น4,198-10%
2015-โ‚น4,665138.1%
2014-โ‚น1,95940%
2013-โ‚น1,399-25%
2012-โ‚น1,86666.67%
2011-โ‚น1,120

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น126.88-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น322.80-194.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น33.59-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น269.62-178.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น362.91 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น1,049 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น131.54-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA